Source BioScience completes £18.5m strategic acquisition of LDPath Ltd to reimagine the future of pathology by combining cellular and digital pathology platforms
Source BioScience, an Established Provider of Testing Services to the NHS, Secures Overnight Funding to Enable It to Accelerate Its Offering of COVID-19 Testing for Frontline Workers